Abstract Body

The current year has heralded a revolution in automated insulin delivery (AID) systems. There are currently 2 approved AIDs in the United States with anticipation of a 3^rd approved system within the next few months, in addition to the Do-It-Yourself (DIY) systems. Shortly thereafter, we expect a number of other AID systems to become available globally. In order to ensure uptake of these advanced diabetes technologies, it is important to understand patient preferences.
A number of studies have employed qualitative research methods to understand the desires of persons with diabetes of all ages, from childhood through older aged adults as well as the care providers of children and significant others of adults. It is important to keep in mind the need for realistic expectations of what current systems can and cannot do with respect to insulin automation. For example, there continues to be need for meal announcements with carbohydrate entry. Future advanced systems may mitigate this requirement.
At this time, it remains important to understand patient preferences with regard to type of device (e.g., on-body, pod device vs. tubed insulin pump that can be removed as needed during wear). In addition, use of continuous glucose monitors (CGM) remains critical in such systems; therefore, preferences with regard to CGM must be also considered. It is also important to understand the various controllers and where such controllers reside (e.g., in pump, on handheld device) that implement the AID algorithm. This session will include review of various studies reporting patient preferences.